Search Results

There are 20867 results for: content related to: Therapy of hepatitis C: Consensus interferon trials

  1. You have free access to this content
    A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C

    Hepatology

    Volume 34, Issue 2, August 2001, Pages: 395–403, Karen L. Lindsay, Christian Trepo, Tobias Heintges, Mitchell L. Shiffman, Stuart C. Gordon, John C. Hoefs, Eugene R. Schiff, Zachary D. Goodman, Mark Laughlin, Ruji Yao and Janice K. Albrecht

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2001.26371

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin

    Journal of Viral Hepatitis

    Volume 19, Issue 4, April 2012, Pages: 263–270, D. A. Kelly, B. Haber, R. P. González-Peralta, K. F. Murray, M. M. Jonas, J. P. Molleston, M. R. Narkewicz, F. R. Sinatra, T. Lang, A. Lachaux, S. Wirth, M. Shelton, H. S. Te, H. Pollack, W. Deng, S. Noviello and J. K. Albrecht

    Article first published online : 17 NOV 2011, DOI: 10.1111/j.1365-2893.2011.01544.x

  4. Abstract of Papers Submitted to the American Association of the Study of Liver Disease

    Hepatology

    Volume 22, Issue S4, October 1995, Pages: S107–S514,

    Article first published online : 5 DEC 2005, DOI: 10.1002/hep.1840220703

  5. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Article first published online : 19 SEP 2007, DOI: 10.1002/hep.22017

  6. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Article first published online : 5 OCT 2005, DOI: 10.1002/hep.20927

  7. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Article first published online : 2 DEC 2008, DOI: 10.1002/hep.22759

  8. You have free access to this content
    Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics

    Hepatology

    Volume 42, Issue 5, November 2005, Pages: 1010–1018, Regino P. González-Peralta, Deirdre A. Kelly, Barbara Haber, Jean Molleston, Karen F. Murray, Maureen M. Jonas, Mark Shelton, Giorgina Mieli-Vergani, Yoav Lurie, Steven Martin, Thomas Lang, Andrew Baczkowski, Michael Geffner, Samir Gupta and Mark Laughlin

    Article first published online : 25 OCT 2005, DOI: 10.1002/hep.20884

  9. Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 6, June 2001, Pages: 407–421, J. Frank Jen, Paul Glue, Farkad Ezzet, Carol Chung, Samir K. Gupta, Sheila Jacobs and Gerald Hajian

    Article first published online : 19 JUN 2001, DOI: 10.1067/mcp.2001.115872

  10. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Article first published online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  11. Abstracts of the international association for the study of the liver biennial Scientific meeting

    Hepatology

    Volume 19, Issue 4, April 1994, Pages: I1–I144,

    Article first published online : 5 DEC 2005, DOI: 10.1002/hep.1840190444

  12. You have free access to this content
    Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 4, April 2000, Pages: 463–469, Lo Iacono, Castro, Diago, Moreno, Fernandez-Bermejo, Vega, García, Carbonell, Sanz, Borque, García-Buey, García-Monzón, Pedreira and Moreno-Otero

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00713.x

  13. You have free access to this content
    AASLD Abstract (pp. 162A–266A)

    Hepatology

    Volume 40, Issue S4, October 2004, Pages: 267A–369A,

    Article first published online : 10 FEB 2006, DOI: 10.1002/hep.1840400504

  14. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26880

  15. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  16. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Article first published online : 24 SEP 2008, DOI: 10.1002/hep.22645

  17. You have free access to this content
    Abstracts 259 to 542

    Hepatology

    Volume 44, Issue S1, October 2006, Pages: 287A–390A,

    Article first published online : 25 SEP 2006, DOI: 10.1002/hep.21396

  18. You have free access to this content
    Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison

    Hepatology

    Volume 26, Issue 6, December 1997, Pages: 1640–1645, M J Tong, L M Blatt, J G McHutchison, R L Co and A Conrad

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510260637

  19. American association for the study of liver diseases

    Hepatology

    Volume 16, Issue S4, October 1992, Pages: 1A–292A,

    Article first published online : 5 DEC 2005, DOI: 10.1002/hep.1840160702

  20. Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: 120–127, J. Vermehren, S. Susser, C. M. Lange, N. Forestier, U. Karey, E. Hughes, R. Ralston, X. Tong, S. Zeuzem and C. Sarrazin

    Article first published online : 1 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01449.x